https://www.selleckchem.com/pr....oducts/PCI-24781.htm
The outcome was favorable with good approximation and healing with preserved range of motion. The therapeutic challenge of glioblastoma (GBM) has catalyzed the development of clinical trials to evaluate novel interventions. With increased understanding of GBM biology and technological advances, the neurosurgeon's role in neuro-oncology has evolved. To evaluate the current landscape of procedure-based clinical trials for GBM to characterize this evolution, gain insight into past failures, and accordingly outline implications for future
Like
Comment
Share
